1. Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial. Issue 10379 (11th March 2023) Authors: Motzer, Robert J; Russo, Paul; Grünwald, Viktor; Tomita, Yoshihiko; Zurawski, Bogdan; Parikh, Omi; Buti, Sebastiano; Barthélémy, Philippe; Goh, Jeffrey C; Ye, Dingwei; Lingua, Alejo; Lattouf, Jean-Baptiste; Albigès, Laurence; George, Saby; Shuch, Brian; Sosman, Jeffrey; Staehler, Michael; Vázquez... Journal: Lancet Issue: Volume 401:Issue 10379(2023) Page Start: 821 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Analysis of female demographics in the United States: life expectancy, education, employment, family building decisions, and fertility service utilization. Issue 3 (June 2021) Authors: Esencan, Ecem; Simsek, Burcin; Seli, Emre Journal: Current opinion in obstetrics and gynecology Issue: Volume 33:Issue 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial. Issue 7 (July 2022) Authors: Motzer, Robert J; Powles, Thomas; Burotto, Mauricio; Escudier, Bernard; Bourlon, Maria T; Shah, Amishi Y; Suárez, Cristina; Hamzaj, Alketa; Porta, Camillo; Hocking, Christopher M; Kessler, Elizabeth R; Gurney, Howard; Tomita, Yoshihiko; Bedke, Jens; Zhang, Joshua; Simsek, Burcin; Scheffold, Chris... Journal: Lancet oncology Issue: Volume 23:Issue 7(2022) Page Start: 888 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Nivolumab plus ipilimumab plus cabozantinib triplet combination for patients with previously untreated advanced renal cell carcinoma: Results from a discontinued arm of the phase III CheckMate 9ER trial. (December 2022) Authors: Apolo, Andrea B.; Powles, Thomas; Escudier, Bernard; Burotto, Mauricio; Zhang, Joshua; Simsek, Burcin; Scheffold, Christian; Motzer, Robert J.; Choueiri, Toni K. Journal: European journal of cancer Issue: Volume 177(2022) Page Start: 63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. On Certain Mathematical Problems in Two-Photon Laser Scanning Microscopy. Issue 5 (3rd September 2017) Authors: Simsek, Burcin; Iyengar, Satish Journal: Mathematical modelling and analysis Issue: Volume 22:Issue 5(2017) Page Start: 587 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma. Issue 1 (4th June 2020) Authors: Ascierto, Paolo Antonio; Del Vecchio, Michelle; Mackiewicz, Andrzej; Robert, Caroline; Chiarion-Sileni, Vanna; Arance, Ana; Lebbé, Céleste; Svane, Inge Marie; McNeil, Catriona; Rutkowski, Piotr; Loquai, Carmen; Mortier, Laurent; Hamid, Omid; Bastholt, Lars; Dreno, Brigitte; Schadendorf, Dirk; Gar... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, randomised, phase 3 trial. Issue 2 (February 2022) Authors: Cella, David; Motzer, Robert J; Suarez, Cristina; Blum, Steven I; Ejzykowicz, Flavia; Hamilton, Melissa; Wallace, Joel F; Simsek, Burcin; Zhang, Joshua; Ivanescu, Cristina; Apolo, Andrea B; Choueiri, Toni K Journal: Lancet oncology Issue: Volume 23:Issue 2(2022) Page Start: 292 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma. (November 2017) Authors: Geoerger, Birgit; Bergeron, Christophe; Gore, Lia; Sender, Leonard; Dunkel, Ira J.; Herzog, Cynthia; Brochez, Lieve; Cruz, Ofelia; Nysom, Karsten; Berghorn, Elmer; Simsek, Burcin; Shen, Jun; Pappo, Alberto Journal: European journal of cancer Issue: Volume 86(2017) Page Start: 358 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Which Sleep Health Characteristics Predict All-Cause Mortality in Older Men? An Application of Flexible Multivariable Approaches. Issue 1 (20th November 2017) Authors: Wallace, Meredith L; Stone, Katie; Smagula, Stephen F; Hall, Martica H; Simsek, Burcin; Kado, Deborah M; Redline, Susan; Vo, Tien N; Buysse, Daniel J Journal: Sleep Issue: Volume 41:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗